These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3532752)

  • 1. Comparison of nitrendipine with propranolol and its use in combined cardiovascular therapy.
    McMahon FG
    Am J Cardiol; 1986 Sep; 58(8):8D-11D. PubMed ID: 3532752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison and additivity of nitrendipine and hydrochlorothiazide in systemic hypertension.
    Massie BM; Tubau JF; Szlachcic J; Vollmer C
    Am J Cardiol; 1986 Sep; 58(8):16D-19D. PubMed ID: 3532749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive therapy with nitrendipine: comparison with hydrochlorothiazide and propranolol.
    Massie BM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S55-8. PubMed ID: 2468874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of oral nitrendipine and propranolol, alone and in combination, on hypertensive patients with special reference to AV conduction.
    Maltz MB; Davies DW; Lau CP; Creamer JE; Banim SO; Camm AJ
    Br J Clin Pharmacol; 1986 Oct; 22(4):463-7. PubMed ID: 3533128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrendipine as an antihypertensive agent.
    Zachariah PK
    Eur Heart J; 1987 Nov; 8 Suppl K():63-7. PubMed ID: 3330031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity and mortality on combination versus monotherapy: a posthoc analysis of the Systolic Hypertension in Europe trial.
    Thijs L; Richart T; de Leeuw PW; Kuznetsova T; Grodzicki T; Kawecka-Jaszcz K; O'Brien E; Redón J; Birkenhäger WH; Fagard R; Staessen JA
    J Hypertens; 2010 Apr; 28(4):865-74. PubMed ID: 20051905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the calcium channel blocker nitrendipine on left ventricular mass in patients with hypertension.
    Drayer JI; Hall WD; Smith VE; Weber MA; Wollam GL; White WB
    Clin Pharmacol Ther; 1986 Dec; 40(6):679-85. PubMed ID: 3780130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and metabolic effects of the calcium channel blocking agent nitrendipine.
    Johnson BF; Romero L; Marwaha R
    Clin Pharmacol Ther; 1986 Apr; 39(4):389-94. PubMed ID: 2937598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.
    Fagan TC; Sternleib C; Vlachakis N; Deedwania PC; Mehta JL
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1109-13. PubMed ID: 6085377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossover comparison of nitrendipine with propranolol in patients with essential hypertension.
    Fritschka E; Distler A; Gotzen R; Thiede HM; Philipp T
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1100-4. PubMed ID: 6085375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of quality of life on nitrendipine and propranolol.
    Zachariah PK; Brobyn R; Kann J; Levy B; Margolis R; McMahon FG; Reeves R; Sperling DC; Sweet D; Zager P
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S29-35. PubMed ID: 2468871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrendipine treatment in so-called therapy-resistant arterial hypertension; effect as monotherapy and in combination with propranolol on blood pressure, heart rate, other hemodynamic parameters, plasma renin activity, and catecholamines.
    Faulhaber HD; Gruner R; Homuth V; Naumann E; Menz M; Hartrodt W; Schmidt J; Mohnike W
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S146-8. PubMed ID: 2468860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium entry blockade or beta-blockade in long-term management of hypertension in blacks.
    M'Buyamba-Kabangu JR; Fagard R; Lijnen P; Staessen J; Lissens W; Ditu M; Lepira B; Tshiani KA; Amery A
    Clin Pharmacol Ther; 1987 Jan; 41(1):45-54. PubMed ID: 3802705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure.
    Kloke HJ; Huysmans FT; Wetzels JF; Sluiter HE; Kleinbloesem CH; Koene RA
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):289S-296S. PubMed ID: 2527541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists: use in hypertension evaluation of calcium antagonists in combination with diuretics.
    Schoenberger JA
    Angiology; 1988 Jan; 39(1 Pt 2):87-93. PubMed ID: 3277494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.
    Philipp T; Anlauf M; Distler A; Holzgreve H; Michaelis J; Wellek S
    BMJ; 1997 Jul; 315(7101):154-9. PubMed ID: 9251545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged calcium channel blocker therapy of hypertension.
    Weber MA
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S16-21. PubMed ID: 2468864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
    Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R
    N Engl J Med; 1999 Mar; 340(9):677-84. PubMed ID: 10053176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA; Drayer JI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension.
    de Divitiis O; Petitto M; Di Somma S; Galderisi M; Villari B; Santomauro M; Fazio S
    Arzneimittelforschung; 1985; 35(4):727-9. PubMed ID: 3160356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.